PhD, CEO & Co-Founder of HAYA Therapeutics
PhD, CEO & Co-Founder of HAYA Therapeutics
Samir Ounzain is a molecular biologist with over 15 years of experience exploring the dark matter of the genome and its roles in development and disease. Prior to founding HAYA Therapeutics, Samir was a Project Leader and Research Fellow at the Lausanne University Hospital (CHUV), where his research efforts directly led to the discovery of hundreds of novel heart-enriched lncRNAs, most notably the lncRNAs CARMEN, Meteor and Wisper.
PhD, CEO & Co-Founder of HAYA Therapeutics